IHT Wealth Management’s Anika Therapeutics ANIK Stock Holding History

IHT Wealth Management’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,025	Closed	-$49K	–	458
2018 Q1	$49K	Hold	1,025	–	–	0.01%	683
2017 Q4	$57K	Buy	1,025 +110	+12%	+$6.09K	0.02%	657
2017 Q3	$55K	Buy	915 +100	+12%	+$5.23K	0.02%	493
2017 Q2	$2.56M	Sell	815 -50	-6%	-$2.3K	1.24%	8
2017 Q1	$38K	Hold	865	–	–	0.03%	486
2016 Q4	$43K	Buy	+865	New	+$40K	0.03%	416

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

IHT Wealth Management's ANIK Position: Q2 2018 in Review

IHT Wealth Management sold out of Anika Therapeutics (ANIK) in Q2 2018, closing a stake of 1,025 shares — an estimated $49K sold.

IHT Wealth Management first reported a position in ANIK in Q4 2016 and held it in 6 quarters. The position peaked at $2.56M in Q2 2017. 170 funds tracked by Wall St. Rank hold ANIK as of Q2 2018.

IHT Wealth Management reported no remaining Anika Therapeutics position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 1,025 Anika Therapeutics shares in Q2 2018, an estimated $49K.
IHT Wealth Management first reported a position in Anika Therapeutics in Q4 2016 and held it in 6 quarters.
IHT Wealth Management's Anika Therapeutics position peaked at $2.56M in Q2 2017.
170 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.